Calliditas Therapeutics

Major Shareholding Notification • Aug 6, 2024

Issuer Calliditas Therapeutics AB

Holder

195303 Bengt Julander

Instrument

Instrument	Common SE0010441584
Before the transaction
Shares	5,962,312
Voting rights	5,962,312
Transaction
Reason for major shareholding notification Other
Date	31/07/2024
Limit for number of shares	10 %
Limit for number of votes	10 %
After the transaction
Quantity
Shares	5,962,312
Directly held voting rights	0
Indirectly held voting rights	5,962,312
Percentage
Directly held shares	10.00722 %
Directly held voting rights	0 %
Indirectly held voting rights	9.94689 %

Resulting distribution of total holdings

	Percentage of voting rights:	Number of underlying shares:
Shares	9.94689 %	5,962,312
Instruments - FITA Ch. 4, section 2, first paragraph, line 2
Instruments - FITA Ch. 4, section 2, first paragraph, line 3
- Physically settled
- Cash settled
Total	9.94689 %	5,962,312
Chain of controlling companies
Voting rights % Voting rights Company
5,962,312 9.94689 Linc AB
Group total holdings
Voting rights 5,962,312
Percentage of voting rights 9.94689
Notes (other relevant informations according to law)
Changes due to: Dilution due to increase in number of shares
Published 06/08/2024 11:00
Contact
Phone 0703195909 Email bengt.julander@linc.se

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25